December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Surgical Treatment in Uveitic Glaucoma
Author Affiliations & Notes
  • L Arellanes-Garcia
    Uveitis Asoc Evitar la Ceguera Mex IAP Mexico City Mexico
  • SC Quintero-y De León
    Enfermedades Inflamatorias Oculares Asociación Para Evitar la Ceguera en México México DF Mexico
  • P Navarro-López
    Enfermedades Inflamatorias Oculares Asociación Para Evitar la Ceguera en México México DF Mexico
  • D Alvares-Celorio
    Enfermedades Inflamatorias Oculares Asociación Para Evitar la Ceguera en México México DF Mexico
  • F Gil-Carrasco
    Enfermedades Inflamatorias Oculares Asociación Para Evitar la Ceguera en México México DF Mexico
  • E Salinas-Van Orman
    Enfermedades Inflamatorias Oculares Asociación Para Evitar la Ceguera en México México DF Mexico
  • Footnotes
    Commercial Relationships   L. Arellanes-Garcia, None; S.C. Quintero-y De León, None; P. Navarro-López, None; D. Alvares-Celorio, None; F. Gil-Carrasco, None; E. Salinas-Van Orman, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3375. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L Arellanes-Garcia, SC Quintero-y De León, P Navarro-López, D Alvares-Celorio, F Gil-Carrasco, E Salinas-Van Orman; Surgical Treatment in Uveitic Glaucoma . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3375.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To assess the outcome of different surgical techniques in the treatment of uncontrolled uveitic glaucoma patients. Methods:The clinical files of all patients with uncontrolled uveitic glaucoma requiring surgical treatment, seen from September 1988 to April 2001 were retrospectively reviewed. Overall success was defined as Intraocular Pressure (IOP) between 6-21mmHg with or without anti-glaucomatous therapy. Results:We included 108 eyes of 108 patients, 67% were females, mean age was 46 years (range 4 -83 years). Mean postoperative follow up was 32 months (range 16-48 months). Uveitic etiologies were: Idiopathic Anterior Uveitis 26.85%, Fuch’s heterochromic iridocyclitis 18.51%, Vogt Koyanagi Harada disease 17.5%, Herpetic Keratouveitis 13.8%, Pars Planitis 11.1%, others 12.06%. Trabeculectomy (T) was performed in 16% of the patients, Trabeculectomy+Mitomycin C (T+MMC) in 40%, Ahmed Valve Implant (AVI) in 35% and sclerectomy (S) in 9%. Preoperatively 91% of cases had none to mild ocular inflammation. Trabeculectomy had an overall success rate of 83%, T + MMC 97%, AVI 87%, and S 80%. Complications occurred in 54% of the patients who underwent T, 40% in T-MMC, 30% in AVI, and 33% in S. The most common complications were choroidal detachment (16%), seidel (12%), cystic bleb (12%)in T-MMC, and choroidal detachment (8%), cystic bleb (11%), and corneal edema (11%) in AVI. Conclusion:: T-MMC and AVI were the most effective techniques in lowering the IOP.

Keywords: 612 uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×